tiprankstipranks
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
US Market
VRCA
Verrica Pharmaceuticals
RESEARCH TOOLSreports
Want to see VRCA full AI Analyst Report?

Verrica Pharmaceuticals (VRCA) Stock News & Sentiment

483 Followers
Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating
Premium
Ratings
Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating
2M ago
VRCA
Verrica Pharmaceuticals (VRCA) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Verrica Pharmaceuticals (VRCA) Q4 Earnings Cheat Sheet
2M ago
VRCA
YCANTH Phase 3 Wart Study Puts Verrica in Focus While Veeva Extends Its Clinical Footprint
Premium
Company Announcements
YCANTH Phase 3 Wart Study Puts Verrica in Focus While Veeva Extends Its Clinical Footprint
3M ago
VEEV
VRCA
Verrica Pharmaceuticals Adds Caligan Partner to Board
Premium
Company Announcements
Verrica Pharmaceuticals Adds Caligan Partner to Board
4M ago
8K
VRCA
Verrica Pharmaceuticals: Hold Rating Amid Strategic Debt Retirement and Dilution Concerns
Premium
Ratings
Verrica Pharmaceuticals: Hold Rating Amid Strategic Debt Retirement and Dilution Concerns
5M ago
VRCA
Verrica Pharmaceuticals Secures $50M Financing Deal
Premium
Company Announcements
Verrica Pharmaceuticals Secures $50M Financing Deal
5M ago
8K
VRCA
Verrica Pharmaceuticals Reports Strong Growth Amid Challenges
Premium
Company Announcements
Verrica Pharmaceuticals Reports Strong Growth Amid Challenges
5M ago
VRCA
More VRCA News >

VRCA News on the Web

Analysts Have Conflicting Sentiments on These Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Johnson & Johnson (JNJ)
TipRanks News
Neutral
Verrica Pharmaceuticals Faces Director Oversight Probe: What Investors Should Know After Rosen Law Firm Announcement
Market Chameleon
Neutral
Verrica Pharma Q4 And FY25 Revenue Improves; Plans Second Phase 3 Program For VP-102 In Mid 2026
rttnews
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR)
TipRanks News
Neutral
Verrica Pharmaceuticals Inc (VRCA) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ...
GuruFocus News
Bullish
Q4 2025 Verrica Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News
Neutral
Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating
TipRanks News
Bullish
Verrica Pharmaceuticals reports Q4 adjusted EPS (51c), consensus (79c)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
VRCA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRCA’s Media Buzz Sentiment?
1 articles about VRCA were published this week. In an average week, 1 articles are published.
    What is VRCA’s weekly average amount of articles?
    In an average week, 1 articles about VRCA are published.
      What is VRCA’s News Sentiment?
      50% of articles about VRCA were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week